Seres Therapeutics Inc (NASDAQ:MCRB)
| 25.00 Delayed Data As of 7:50pm ET |  +0.52 / +2.12%Today’s Change | 2.52 Today|||52-Week Range 38.50 | +2.04% Year-to-Date |
Latest MCRB News | Press Releases
| Avoid These Recently Downgraded Stocks: Luminar Technologies, Seres Therapeutics, Sabre Corporation, and Murphy Oil 8:53am / StockNews.com - Paid Partner Content |
Today’s Trading
| Previous close | 24.48 |
| Today’s open | 25.79 |
| Day’s range | 24.29 - 25.95 |
| Volume | 98,609 |
| Average volume (3 months) | 897,442 |
| Market cap | $2.2B |
Data as of 7:50pm ET, 01/19/2021
Growth & Valuation
| Earnings growth (last year) | +48.91% |
| Earnings growth (this year) | +11.09% |
| Earnings growth (next 5 years) | -4.75% |
| Revenue growth (last year) | +22.07% |
| P/E ratio | NM |
| Price/Sales | 5.66 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SGMOSangamo Therapeutics... | -0.18 | -1.14% |
| ---- | ||
| STOKStoke Therapeutics I... | +3.49 | +5.24% |
| RCUSArcus Biosciences In... | -0.23 | -0.62% |
Data as of 5:42pm ET, 01/19/2021
Financials
| Next reporting date | March 10, 2021 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $34.5M |
| Annual profit (last year) | -$70.3M |
| Net profit margin | -203.68% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
